PDF
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
326kB |
Item Type: | Article |
---|---|
Title: | Tumor rejection by modulation of tumor stromal fibroblasts |
Creators Name: | Schueler, T., Koernig, S. and Blankenstein, T. |
Abstract: | Interleukin (IL)-4-secreting tumors are rejected in mice, an effect that is thought to be immune mediated. However, solid tumors are embedded in a stroma that often contains tumor-promoting fibroblasts, a cell population whose function is also affected by IL-4. Here we show that IL-4-secreting tumors grew undiminished in IL-4 receptor (R)-deficient (IL-4R-/-) mice. In IL-4R+/+ mice they were long-term suppressed in the absence of T cells but complete rejection required T cells, compatible with the assumption that hematopoietic cells needed to respond to IL-4. Surprisingly, bone marrow (BM) chimeric mice revealed that IL-4R expression exclusively on non-BM-derived cells was sufficient for tumor rejection. Fibroblasts in the tumor stroma were identified as a target cell type for IL-4 because they accumulated in IL-4-secreting tumors and displayed an activated phenotype. Additionally, coinjection of IL-4R+/+ but not IL-4R-/- fibroblasts was sufficient for the rejection of IL-4-secreting tumors in IL-4R-/- mice. Our data demonstrate a novel mechanism by which IL-4 contributes to tumor rejection and show that the targeted modulation of tumor-associated fibroblasts can be sufficient for tumor rejection. |
Keywords: | IL-4 Receptor, Bone Marrow Transplantation, Angiogenesis, Collagen, Animals, Mice |
Source: | Journal of Experimental Medicine |
ISSN: | 0022-1007 |
Publisher: | Rockefeller University Press |
Volume: | 198 |
Number: | 10 |
Page Range: | 1487-1493 |
Date: | 17 November 2003 |
Official Publication: | https://doi.org/10.1084/jem.20030849 |
PubMed: | View item in PubMed |
Repository Staff Only: item control page